Literature DB >> 29107805

Neuronal expression patterns of the PlexinA family during zebrafish development.

Sarah E Emerson1, Sarah E Light1, Alicia M Ebert2.   

Abstract

Plexins (Plxns) and Semaphorins (Semas) are key signaling molecules that regulate many aspects of development. Plxns are a family of transmembrane protein receptors that are activated upon extracellular binding by Semas. Activated Plxns trigger intracellular signaling cascades, which regulate a range of developmental processes, including axon guidance, neuronal positioning and vasculogenesis. Semas are a large family of both transmembrane and secreted signaling molecules, and show subtype specific binding to different Plxn family members. Each Plxn can play different roles in development, and so tightly regulated temporal and spatial expression of receptor subtypes is critical to ensure appropriate signaling. Here we elucidate the expression profiles of the plxnA family, plxnA1a, A1b, A2, A3 and A4 at 18, 24, 36, 48, 60 and 72 h post fertilization in the developing zebrafish. We show that PlxnA family members are expressed in neuronal tissues during zebrafish development, but exhibit key differences in expression within these tissues. We also highlight that plxnA1 has two genes in zebrafish, A1a and A1b, which show divergences in expression patterns during early development.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Eye development; In situ hybridization; Retina; Semaphorin; plexinA1a; plexinA1b

Mesh:

Substances:

Year:  2017        PMID: 29107805     DOI: 10.1016/j.gep.2017.10.007

Source DB:  PubMed          Journal:  Gene Expr Patterns        ISSN: 1567-133X            Impact factor:   1.224


  1 in total

1.  Biallelic and monoallelic variants in PLXNA1 are implicated in a novel neurodevelopmental disorder with variable cerebral and eye anomalies.

Authors:  Gabriel C Dworschak; Jaya Punetha; Jeshurun C Kalanithy; Enrico Mingardo; Haktan B Erdem; Zeynep C Akdemir; Ender Karaca; Tadahiro Mitani; Dana Marafi; Jawid M Fatih; Shalini N Jhangiani; Jill V Hunter; Tikam Chand Dakal; Bhanupriya Dhabhai; Omar Dabbagh; Hessa S Alsaif; Fowzan S Alkuraya; Reza Maroofian; Henry Houlden; Stephanie Efthymiou; Natalia Dominik; Vincenzo Salpietro; Tipu Sultan; Shahzad Haider; Farah Bibi; Holger Thiele; Julia Hoefele; Korbinian M Riedhammer; Matias Wagner; Ilaria Guella; Michelle Demos; Boris Keren; Julien Buratti; Perrine Charles; Caroline Nava; Delphine Héron; Solveig Heide; Elise Valkanas; Leigh B Waddell; Kristi J Jones; Emily C Oates; Sandra T Cooper; Daniel MacArthur; Steffen Syrbe; Andreas Ziegler; Konrad Platzer; Volkan Okur; Wendy K Chung; Sarah A O'Shea; Roy Alcalay; Stanley Fahn; Paul R Mark; Renzo Guerrini; Annalisa Vetro; Beth Hudson; Rhonda E Schnur; George E Hoganson; Jennifer E Burton; Meriel McEntagart; Tobias Lindenberg; Öznur Yilmaz; Benjamin Odermatt; Davut Pehlivan; Jennifer E Posey; James R Lupski; Heiko Reutter
Journal:  Genet Med       Date:  2021-05-30       Impact factor: 8.822

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.